Citizens Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.6M | Sell |
269,662
-6,532
| -2% | -$754K | 0.45% | 47 |
|
|
2025
Q4 | $29.1M | Sell |
276,194
-6,599
| -2% | -$619K | 0.39% | 50 |
|
|
2025
Q3 | $23.9M | Buy |
282,793
+1,703
| +0.6% | +$140K | 0.33% | 60 |
|
|
2025
Q2 | $22.3M | Sell |
281,090
-39,355
| -12% | -$3.13M | 0.36% | 61 |
|
|
2025
Q1 | $28.8M | Buy |
320,445
+89,123
| +39% | +$8.32M | 0.57% | 32 |
|
|
2024
Q4 | $23M | Sell |
231,322
-12,675
| -5% | -$1.31M | 0.45% | 47 |
|
|
2024
Q3 | $27.8M | Buy |
243,997
+7,769
| +3% | +$923K | 0.56% | 34 |
|
|
2024
Q2 | $29.2M | Buy |
236,228
+32,009
| +16% | +$4.12M | 0.65% | 28 |
|
|
2024
Q1 | $26.9M | Sell |
204,219
-6,525
| -3% | -$804K | 0.9% | 22 |
|
|
2023
Q4 | $23M | Buy |
210,744
+17,532
| +9% | +$1.82M | 0.79% | 24 |
|
|
2023
Q3 | $19.9M | Sell |
193,212
-9,607
| -5% | -$1.04M | 0.81% | 27 |
|
|
2023
Q2 | $23.4M | Sell |
202,819
-9,421
| -4% | -$1.07M | 0.85% | 23 |
|
|
2023
Q1 | $22.6M | Buy |
212,240
+6,623
| +3% | +$715K | 0.83% | 21 |
|
|
2022
Q4 | $22.8M | Sell |
205,617
-9,821
| -5% | -$1M | 0.89% | 22 |
|
|
2022
Q3 | $18.6M | Buy |
215,438
+545
| +0.3% | +$48.7K | 0.82% | 24 |
|
|
2022
Q2 | $19.6M | Buy |
214,893
+57,402
| +36% | +$5.09M | 0.82% | 26 |
|
|
2022
Q1 | $12.9M | Buy |
157,491
+114,125
| +263% | +$9M | 0.45% | 52 |
|
|
2021
Q4 | $3.27M | Buy |
43,366
+247
| +0.6% | +$19.7K | 0.11% | 131 |
|
|
2021
Q3 | $3.25M | Buy |
43,119
+10,124
| +31% | +$770K | 0.12% | 127 |
|
|
2021
Q2 | $2.57M | Buy |
32,995
+2,688
| +9% | +$200K | 0.11% | 122 |
|
|
2021
Q1 | $2.23M | Buy |
30,307
+1,938
| +7% | +$143K | 0.12% | 118 |
|
|
2020
Q4 | $2.21M | Sell |
28,369
-657
| -2% | -$50.2K | 0.13% | 114 |
|
|
2020
Q3 | $2.28M | Sell |
29,026
-1,550
| -5% | -$121K | 0.15% | 107 |
|
|
2020
Q2 | $2.26M | Sell |
30,576
-1,428
| -4% | -$108K | 0.16% | 105 |
|
|
2020
Q1 | $2.36M | Buy |
32,004
+3,735
| +13% | +$294K | 0.19% | 96 |
|
|
2019
Q4 | $2.45M | Buy |
28,269
+4,147
| +17% | +$341K | 0.16% | 103 |
|
|
2019
Q3 | $1.94M | Sell |
24,122
-689
| -3% | -$55.2K | 0.14% | 106 |
|
|
2019
Q2 | $1.99M | Sell |
24,811
-1,606
| -6% | -$123K | 0.15% | 106 |
|
|
2019
Q1 | $2.1M | Buy |
26,417
+1,024
| +4% | +$76.6K | 0.15% | 104 |
|
|
2018
Q4 | $1.85M | Sell |
25,393
-389
| -2% | -$27.5K | 0.17% | 100 |
|
|
2018
Q3 | $1.75M | Buy |
25,782
+1,123
| +5% | +$71.5K | 0.14% | 108 |
|
|
2018
Q2 | $1.43M | Sell |
24,659
-2,221
| -8% | -$125K | 0.12% | 111 |
|
|
2018
Q1 | $1.4M | Sell |
26,880
-2,351
| -8% | -$127K | 0.12% | 111 |
|
|
2017
Q4 | $1.57M | Sell |
29,231
-1,433
| -5% | -$79.4K | 0.13% | 107 |
|
|
2017
Q3 | $1.87M | Buy |
30,664
+4,376
| +17% | +$265K | 0.16% | 106 |
|
|
2017
Q2 | $1.61M | Sell |
26,288
-2,362
| -8% | -$144K | 0.14% | 108 |
|
|
2017
Q1 | $1.74M | Sell |
28,650
-5,874
| -17% | -$356K | 0.15% | 104 |
|
|
2016
Q4 | $1.94M | Sell |
34,524
-1,642
| -5% | -$96.1K | 0.19% | 96 |
|
|
2016
Q3 | $2.15M | Sell |
36,166
-2,158
| -6% | -$126K | 0.2% | 95 |
|
|
2016
Q2 | $2.11M | Sell |
38,324
-2,345
| -6% | -$125K | 0.2% | 95 |
|
|
2016
Q1 | $2.05M | Buy |
40,669
+2,376
| +6% | +$116K | 0.2% | 93 |
|
|
2015
Q4 | $2.12M | Buy |
+38,293
| New | +$1.93M | 0.2% | 91 |
|
Other funds holding MRK
VCM
VPM
Citizens Financial Group's MRK Position: Q1 2026 in Review
Citizens Financial Group reduced its Merck (MRK) stake by 2.4% in Q1 2026, selling an estimated $754K and leaving 269,662 shares worth $32.6M. The position accounts for 0.45% of the portfolio, ranked #47.
Citizens Financial Group first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Citizens Financial Group held 269,662 shares of Merck worth $32.6M as of Q1 2026.
- Citizens Financial Group sold 6,532 Merck shares in Q1 2026, an estimated $754K.
- Merck made up 0.45% of Citizens Financial Group's portfolio in Q1 2026, its #47 holding.
- Citizens Financial Group first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.